Inventor
WAI-SI ENG
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
C07BGeneral methods of organic chemistry8%
C07CAcyclic or carbocyclic compounds8%
PatentTitleYear
12,564,650Carbonic anhydrase IX-targeting radioactive diagnostic and therapeutic medicament and method for preparing same202612,209,060Ketamine derivatives and compositions thereof202512,172,980Compounds as neuronal histamine receptor-3 antagonists and uses thereof202411,905,247Compounds as neurokinin-1 receptor antagonists and uses thereof202411,440,874Ketamine derivatives and compositions thereof202211,420,955Compounds as neuronal histamine receptor-3 antagonists and uses thereof202211,149,006Compounds as neurokinin-1 receptor antagonists and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to XWPHARMA LTD (6)· patent assignee history
2021Patents assigned to XW LAB INC (1)· patent assignee history
2021–2025Based in US· patent location history
2026Patents assigned to NORROY BIOSCIENCE CO LTD (1)· patent assignee history
2026Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| XWPHARMA LTD | 6 | 2021–2025 |
| NORROY BIOSCIENCE CO LTD | 1 | 2026 |
| XW LAB INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2025 |
| CN | 1 | 2026 |